1. Home
  2. CTRI vs IDYA Comparison

CTRI vs IDYA Comparison

Compare CTRI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

HOLD

Current Price

$30.50

Market Cap

3.2B

Sector

N/A

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$29.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRI
IDYA
Founded
1909
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
CTRI
IDYA
Price
$30.50
$29.30
Analyst Decision
Hold
Strong Buy
Analyst Count
5
16
Target Price
$29.88
$52.86
AVG Volume (30 Days)
1.7M
700.3K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
412.50
61.90
EPS
N/A
N/A
Revenue
$2,982,781,000.00
$218,710,000.00
Revenue This Year
$14.62
N/A
Revenue Next Year
$8.16
$201.05
P/E Ratio
N/A
N/A
Revenue Growth
13.10
3024.43
52 Week Low
$19.04
$19.48
52 Week High
$42.99
$39.28

Technical Indicators

Market Signals
Indicator
CTRI
IDYA
Relative Strength Index (RSI) 42.58 48.52
Support Level $27.77 $27.66
Resistance Level $31.74 $29.50
Average True Range (ATR) 1.32 1.05
MACD -0.34 0.23
Stochastic Oscillator 33.08 71.00

Price Performance

Historical Comparison
CTRI
IDYA

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: